Roche Diagnostics Plans DNA Chip Production In Japan
This article was originally published in PharmAsia News
Executive Summary
The Japanese market for clinical diagnostics has leveled off, but the country continues to demand reagents and equipment to develop new drugs. Roche Diagnostics KK has moved into that market and is set to begin marketing DNA chips in Japan. The plan is part of Roche Diagnostics' emphasis on R&D products to claim a greater share of the sector. One of its plans is to build sequence-capture arrays so drug researchers can determine how variations in gene sequences affect various disorders. (Click here for more - a subscription may be required
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.